Current ideas in COVID vaccines


  • Pornumpa Bunjoungmanee Department of Pediatrics, Faculty of Medicine, Thammasat University


Download data is not yet available.


Tande AJ, Pollock BD, Shah ND,et al. mRNA vaccine effectiveness against asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection over seven months. Infect Control Hosp Epidemiol. 2021;6:1-3.

Tsang NNY, So HC, Cowling BJ, et al. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study. Lancet Infect Dis. 2023;23(4):421-34.

Nyberg T, Ferguson NM, Nash SG, et al. Comparative analysis of the risks of hospitalization and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399:1303-12.

Shrestha NK, Burke PC, Nowacki AS, et al. Effectiveness of the coronavirus disease 2019 (COVID-19) bivalent vaccine. Open Forum Infectious Diseases IDSA. 2023. Accessed May 15, 2023.

Lin DY, Xu Y, Gu Y, et al. Effectiveness of Bivalent Boosters against Severe Omicron Infection. N Engl J Med. 2023;388(8):764-66.

Arbel R, Peretz A, Sergienko R, et al. Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study. Lancet Infect Dis. 2023; Accessed May 15, 2023.

Link-Gelles R, Weber ZA, Reese SE, et al. Estimates of bivalent mRNA vaccine durability in preventing COVID-19–associated hospitalization and critical illness among adults with and without immunocompromising conditionsvision network, September 2022-April 2023. Morb Mortal Wkly Rep. 2023;72(21):579-88.




How to Cite

Bunjoungmanee, P. 2023. Current ideas in COVID vaccines. Asian Medical Journal and Alternative Medicine. 23, 2 (Aug. 2023), 99–101.